Related Experiment Video
Updated: Jan 24, 2026

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory
Published on: February 28, 2013
T2 Mapping at 3 T of Cartilage and Menisci in Patients with Diabetes Mellitus
Ningfan Hu1, Xiaoyun Liang2,3, Jiangtao Zhu1
1Department of Radiology, The Second Affiliated Hospital of Soochow University, 1055 San Xiang Rd, Suzhou, 215004, Jiangsu, China.
Purpose:
The aim of this study was to compare and assess T2 values of compartmental femorotibial cartilage and subregional menisci in patients with diabetes mellitus (DM) at 3 T.
Methods:
Forty-two subjects were enrolled in the study and subdivided into two subgroups: 20 healthy controls (11 females, mean age = 51.6 ± 5.9 years, range 44-67 years) and 22 DM patients (8 females, mean age = 60.1 ± 8.9 years, range 40-75 years). All subjects were evaluated on a 3 T MR scanner applying a 15-channel phased-array knee coil. Wilcoxon rank sum test and analysis of covariance were exploited for detecting group differences, with false discovery rate utilized to control for false positives due to multiple comparisons.
Results:
Lateral tibial cartilage in healthy controls had significantly lower (p < 0.05) T2 values (38.8 ± 5.4 ms) than lateral and medial femoral cartilage, respectively, in DM patients. T2 values of medial body segment (Mc) of meniscus (33.8 ± 8.5 ms) in DM patients were significantly higher (p < 0.05) than those of all subregional menisci except Mc (p = 0.7496) in controls. Mc in controls had significantly higher (p < 0.05) T2 values (31.4 ± 6.3 ms) than lateral and medial anterior horn, and lateral posterior horn of meniscus, respectively, in DM patients.
Conclusion:
T2 values in certain cartilage subcompartments in DM patients are abnormally elevated. T2 mapping may be a potential imaging biomarker for detecting early subtle damage to femorotibial cartilage resulted from DM.
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Growth of Cartilage and Bone Tissue
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Psychoneuroimmunology: Diabetes and Cancer

